'Posterior (SMA-first) Approach' Versus 'Standard Approach' in Terms of Resection Margin and Long-Term Survival After Pancreaticoduodenectomy for Periampullary and Pancreatic Carcinoma: A Randomized Trial.

J Surg OncolSep 3, 2026 (epub)

Hemant Ashok Jain, Gursagar Singh Sahota, Anand Narayan Singh et al.

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial compared the SMA-first approach to the standard approach in pancreaticoduodenectomy for periampullary cancer. Among 183 analyzed patients, both techniques yielded similar R0 resection rates (82.2% vs 78.5%, p = 0.53) and long-term survival outcomes, with median overall survival of 53 months for SMA-first and 51 months for the standard approach.

Key findings

  • R0 resection rates were similar: 82.2% for SMA-first vs 78.5% for standard approach (p = 0.53).
  • Median overall survival was comparable: 53 months for SMA-first vs 51 months for standard approach (p = 0.69).
  • Blood loss was significantly higher in the SMA-first group: 675 ml vs 600 ml (p = 0.02).
  • Complication rates were similar between both groups, including ISGPS Grade B/C leaks and Clavien-Dindo grade ≥III complications.

Why it matters

Understanding the effectiveness of different surgical approaches in pancreaticoduodenectomy is crucial for optimizing patient outcomes. This study suggests that the SMA-first approach does not provide significant advantages over the standard approach in terms of resection margins or survival.

Source

Published in J Surg Oncol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in General Surgery

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.